NASDAQ:ACHV - Achieve Life Sciences Stock Price, Price Target & More

$1.41 +0.11 (+8.46 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$1.30
Today's Range$1.32 - $1.44
52-Week Range$1.15 - $6.27
Volume226,611 shs
Average Volume323,534 shs
Market Capitalization$16.95 million
P/E RatioN/A
Dividend YieldN/A
Beta1.99

About Achieve Life Sciences (NASDAQ:ACHV)

Achieve Life Sciences logoAchieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.

Receive ACHV News and Ratings via Email

Sign-up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryBiotechnology
SectorMedical
SymbolNASDAQ:ACHV
CUSIP68230A10
Phone425-686-1500

Debt

Debt-to-Equity RatioN/A
Current Ratio2.94%
Quick Ratio2.94%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.06 million
Price / Sales3.55
Cash FlowN/A
Price / CashN/A
Book Value$0.66 per share
Price / Book2.14

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-10,580,000.00
Net MarginsN/A
Return on Equity-138.65%
Return on Assets-118.38%

Miscellaneous

Employees13
Outstanding Shares12,750,000

How to Become a New Pot Stock Millionaire

Achieve Life Sciences (NASDAQ:ACHV) Frequently Asked Questions

What is Achieve Life Sciences' stock symbol?

Achieve Life Sciences trades on the NASDAQ under the ticker symbol "ACHV."

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences (NASDAQ:ACHV) announced its quarterly earnings results on Thursday, March, 1st. The biopharmaceutical company reported ($0.32) earnings per share (EPS) for the quarter. View Achieve Life Sciences' Earnings History.

When is Achieve Life Sciences' next earnings date?

Achieve Life Sciences is scheduled to release their next quarterly earnings announcement on Monday, May, 21st 2018. View Earnings Estimates for Achieve Life Sciences.

Who are some of Achieve Life Sciences' key competitors?

Who are Achieve Life Sciences' key executives?

Achieve Life Sciences' management team includes the folowing people:
  • Mr. John A. Bencich M.B.A., Exec. VP, CFO, COO & Principal Accounting Officer (Age 41)
  • Dr. Cindy Jacobs Ph.D., M.D., Exec. VP & Chief Medical Officer (Age 60)
  • Dr. Richard A. B. Stewart, Chairman & CEO (Age 59)
  • Dr. Anthony Clarke Ph.D., Pres, Chief Scientific Officer & Director (Age 62)

Has Achieve Life Sciences been receiving favorable news coverage?

News coverage about ACHV stock has trended positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Achieve Life Sciences earned a news impact score of 0.41 on Accern's scale. They also assigned media stories about the biopharmaceutical company an impact score of 45.77 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Achieve Life Sciences?

Shares of ACHV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Achieve Life Sciences' stock price today?

One share of ACHV stock can currently be purchased for approximately $1.41.

How big of a company is Achieve Life Sciences?

Achieve Life Sciences has a market capitalization of $16.95 million and generates $5.06 million in revenue each year. Achieve Life Sciences employs 13 workers across the globe.

How can I contact Achieve Life Sciences?

Achieve Life Sciences' mailing address is 19820 NORTH CREEK PARKWAY, BOTHELL WA, 98011. The biopharmaceutical company can be reached via phone at 425-686-1500 or via email at [email protected]


MarketBeat Community Rating for Achieve Life Sciences (ACHV)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  266
MarketBeat's community ratings are surveys of what our community members think about Achieve Life Sciences and other stocks. Vote "Outperform" if you believe ACHV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACHV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Achieve Life Sciences (NASDAQ:ACHV) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/26/2016 forward)

Earnings

Achieve Life Sciences (NASDAQ:ACHV) Earnings History and Estimates Chart

Earnings by Quarter for Achieve Life Sciences (NASDAQ:ACHV)

Achieve Life Sciences (NASDAQ ACHV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/21/2018        
3/1/2018Q4 2017($0.32)ViewN/AView Earnings Details
11/9/2017Q3 2017($0.90)ViewN/AView Earnings Details
7/31/2017Q2 2017($0.10)ViewN/AView Earnings Details
5/15/2017Q1 2017($0.29)($0.1120)ViewN/AView Earnings Details
2/23/2017Q4 2016($2.09)ViewN/AView Earnings Details
11/10/2016Q316($0.26)($0.12)ViewN/AView Earnings Details
8/4/2016Q216($0.22)($0.23)$1.17 million$2.10 millionViewN/AView Earnings Details
5/12/2016Q116($0.12)($0.12)$4.09 million$2.90 millionViewListenView Earnings Details
3/9/2016Q4($0.15)($0.06)$6.00 million$6.02 millionViewN/AView Earnings Details
11/12/2015Q3($0.17)($0.16)$5.97 million$6.74 millionViewListenView Earnings Details
8/13/2015Q2$0.34($0.26)$16.10 million$4.03 millionViewListenView Earnings Details
5/14/2015Q115($0.34)($0.20)$4.66 million$1.40 millionViewListenView Earnings Details
3/26/2015Q414($0.30)($0.27)$4.30 million$5.70 millionViewN/AView Earnings Details
10/30/2014($0.38)($0.23)$4.69 million$4.80 millionViewN/AView Earnings Details
8/7/2014($0.55)($0.47)$11.73 million$4.93 millionViewN/AView Earnings Details
4/30/2014($0.50)($0.59)$8.68 million$11.73 millionViewN/AView Earnings Details
3/11/2014Q113($0.66)($0.45)$10.20 million$8.60 millionViewN/AView Earnings Details
11/7/2013Q3 2013($7.59)($7.48)$6.67 million$9.86 millionViewN/AView Earnings Details
8/8/2013Q2 2013($6.93)($6.27)$5.97 million$6.34 millionViewN/AView Earnings Details
5/2/2013Q1 2013($7.48)($6.16)$5.28 million$5.08 millionViewN/AView Earnings Details
3/7/2013Q4 2012($5.39)($4.29)ViewN/AView Earnings Details
11/8/2012Q312($0.49)($0.40)$4.52 million$6.57 millionViewN/AView Earnings Details
8/2/2012Q2 2012($5.94)($3.19)ViewN/AView Earnings Details
5/3/2012Q1 2012($7.59)($5.86)ViewN/AView Earnings Details
3/8/2012Q4 2011($6.49)($10.79)ViewN/AView Earnings Details
11/3/2011Q3 2011($5.94)($4.90)ViewN/AView Earnings Details
8/4/2011Q2 2011($6.05)($7.39)ViewN/AView Earnings Details
5/9/2011Q1 2011($4.95)($5.82)ViewN/AView Earnings Details
3/10/2011Q4 2010($5.28)$3.45ViewN/AView Earnings Details
11/4/2010Q3 2010($5.17)($11.75)ViewN/AView Earnings Details
8/5/2010Q2 2010($4.95)($4.80)ViewN/AView Earnings Details
5/6/2010Q1 2010($4.95)($5.29)ViewN/AView Earnings Details
3/8/2010Q4 2009$2.09($7.04)ViewN/AView Earnings Details
11/5/2009Q3 2009($6.60)($4.35)ViewN/AView Earnings Details
8/6/2009Q2 2009($6.05)($9.04)ViewN/AView Earnings Details
5/7/2009Q1 2009($4.77)ViewN/AView Earnings Details
3/11/2009Q4 2008($10.89)ViewN/AView Earnings Details
11/10/2008Q3 2008$0.78ViewN/AView Earnings Details
3/5/2008Q4 2007($53.42)$10.29ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Achieve Life Sciences (NASDAQ:ACHV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Achieve Life Sciences (NASDAQ ACHV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 35.80%
Institutional Ownership Percentage: 3.76%
Insider Trading History for Achieve Life Sciences (NASDAQ:ACHV)

Achieve Life Sciences (NASDAQ ACHV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/19/2016John BencichCFOSell1,380$0.57$786.605,000View SEC Filing  
6/13/2016Cindy JacobsCMOSell1,437$1.03$1,480.1178,853View SEC Filing  
6/13/2016Scott Daniel CormackCEOSell4,856$1.03$5,001.68134,284View SEC Filing  
3/15/2016Cindy JacobsCMOSell3,254$0.83$2,700.8277,107View SEC Filing  
3/15/2016John BencichCFOSell834$0.83$692.226,698View SEC Filing  
3/15/2016Scott Daniel CormackCEOSell12,033$0.83$9,987.39136,942View SEC Filing  
8/18/2015John BencichCFOSell1,427$2.76$3,938.523,573View SEC Filing  
6/12/2015Cindy JacobsCMOSell1,408$2.69$3,787.52View SEC Filing  
6/12/2015Scott Daniel CormackCEOSell4,571$2.69$12,295.99View SEC Filing  
5/20/2015Cindy JacobsCMOSell2,092$1.88$3,932.96View SEC Filing  
5/20/2015Scott Daniel CormackCEOSell7,543$1.88$14,180.84View SEC Filing  
8/13/2014Cindy JacobsCMOSell5,650$3.17$17,910.50View SEC Filing  
8/13/2014Scott Daniel CormackCEOSell18,341$3.17$58,140.97View SEC Filing  
3/17/2014Cindy JacobsCMOSell1,250$12.25$15,312.5028,905View SEC Filing  
3/17/2014Scott Daniel CormackCEOSell4,634$12.25$56,766.5064,980View SEC Filing  
8/19/2013Cindy JacobsCMOSell1,364$8.68$11,839.5225,780View SEC Filing  
8/19/2013Scott Daniel CormackCEOSell3,112$8.68$27,012.1660,238View SEC Filing  
3/12/2013Scott Daniel CormackCEOSell2,134$11.90$25,394.6056,788View SEC Filing  
8/15/2012Jack GoldsteinDirectorBuy1,000$14.38$14,380.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Achieve Life Sciences (NASDAQ ACHV) News Headlines

Source:
DateHeadline
How to Achieve ROI in Data Analytics Investments Among Highlights of SCIO Health Analytics Top 5 Blog Posts of First ...How to Achieve ROI in Data Analytics Investments Among Highlights of SCIO Health Analytics' Top 5 Blog Posts of First ...
www.prnewswire.com - April 26 at 8:16 AM
Technical Perspectives on Biotech Stocks -- 22nd Century, Abeona Therapeutics, Achieve Life Sciences, and Actinium ...Technical Perspectives on Biotech Stocks -- 22nd Century, Abeona Therapeutics, Achieve Life Sciences, and Actinium ...
www.benzinga.com - April 26 at 8:16 AM
The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to ...The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to ...
www.prnewswire.com - April 18 at 8:16 AM
Galectin Therapeutics to Present at HC Wainwright Global Life Sciences ConferenceGalectin Therapeutics to Present at HC Wainwright Global Life Sciences Conference
globenewswire.com - April 4 at 8:20 AM
Paratek Pharmaceuticals to Present at the HC Wainwright Annual Global Life Sciences ConferenceParatek Pharmaceuticals to Present at the HC Wainwright Annual Global Life Sciences Conference
www.nasdaq.com - March 28 at 8:27 AM
Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or HealthAchieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health
finance.yahoo.com - March 14 at 8:31 AM
This Mornings Technical Outlook on Biotech Stocks -- Acasti Pharma, Achieve Life Sciences, Actinium Pharma, and ... - PR Newswire (press release)This Morning's Technical Outlook on Biotech Stocks -- Acasti Pharma, Achieve Life Sciences, Actinium Pharma, and ... - PR Newswire (press release)
www.prnewswire.com - March 9 at 8:19 AM
Achieve Life Sciences (ACHV) Issues Quarterly  Earnings ResultsAchieve Life Sciences (ACHV) Issues Quarterly Earnings Results
www.americanbankingnews.com - March 2 at 11:39 AM
Achieve Announces Recent Highlights and Reports Year-End 2017 ... - PR Newswire (press release)Achieve Announces Recent Highlights and Reports Year-End 2017 ... - PR Newswire (press release)
www.prnewswire.com - March 2 at 8:15 AM
Achieve Announces Recent Highlights and Reports Year-End 2017 Financial ResultsAchieve Announces Recent Highlights and Reports Year-End 2017 Financial Results
finance.yahoo.com - March 1 at 5:52 PM
Head-To-Head Comparison: Achieve Life Sciences (ACHV) & TG Therapeutics (TGTX)Head-To-Head Comparison: Achieve Life Sciences (ACHV) & TG Therapeutics (TGTX)
www.americanbankingnews.com - February 23 at 5:12 AM
meltmedia Achieves Acquia Foundation Plus Partner Statusmeltmedia Achieves Acquia Foundation Plus Partner Status
www.bizjournals.com - February 20 at 5:47 PM
Achieve Life Sciences cytisine shows encouraging effect in smoking cessation study; shares up 54%Achieve Life Sciences' cytisine shows encouraging effect in smoking cessation study; shares up 54%
seekingalpha.com - February 20 at 5:47 PM
Here’s Why Achieve Life Sciences Inc (ACHV) Jumped as Much as 54% TodayHere’s Why Achieve Life Sciences Inc (ACHV) Jumped as Much as 54% Today
finance.yahoo.com - February 20 at 5:47 PM
Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical StudyAchieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study
finance.yahoo.com - February 20 at 8:16 AM
Global Host Cell Contaminant Testing Market to Reach US$ 354 Mn by 2025 - Persistence Market ResearchGlobal Host Cell Contaminant Testing Market to Reach US$ 354 Mn by 2025 - Persistence Market Research
www.prnewswire.com - February 19 at 5:10 PM
Innovative Cancer Immunotherapy Company, Novelogics Biotechnology, Inc. adds Scott D. Cormack to the Board of Directors to Expand Strategic Growth PlansInnovative Cancer Immunotherapy Company, Novelogics Biotechnology, Inc. adds Scott D. Cormack to the Board of Directors to Expand Strategic Growth Plans
finance.yahoo.com - February 13 at 9:49 AM
A Traders View On Why Bigger Is (Usually) BetterA Trader's View On Why Bigger Is (Usually) Better
finance.yahoo.com - February 2 at 3:47 PM
Achieve Life Sciences Making Progress in the Smoking Cessation Market, Recent EventsAchieve Life Sciences Making Progress in the Smoking Cessation Market, Recent Events
finance.yahoo.com - January 26 at 9:08 AM
What Does Achieve Life Sciences Inc’s (NASDAQ:ACHV) Ownership Structure Look Like?What Does Achieve Life Sciences Inc’s (NASDAQ:ACHV) Ownership Structure Look Like?
finance.yahoo.com - January 24 at 8:07 AM
Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic CategoriesAchieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
finance.yahoo.com - January 24 at 8:07 AM
A Look At Achieve Life Sciences Inc (NASDAQ:ACHV) And The Healthcare SectorA Look At Achieve Life Sciences Inc (NASDAQ:ACHV) And The Healthcare Sector
finance.yahoo.com - January 2 at 7:34 PM
Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking CessationAchieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation
finance.yahoo.com - December 7 at 6:28 PM
ValuEngine Upgrades OncoGenex Pharmaceuticals (ACHV) to SellValuEngine Upgrades OncoGenex Pharmaceuticals (ACHV) to Sell
www.americanbankingnews.com - December 4 at 11:10 PM
OncoGenex Pharmaceuticals Inc. (ACHV) Announces  Earnings ResultsOncoGenex Pharmaceuticals Inc. (ACHV) Announces Earnings Results
www.americanbankingnews.com - November 10 at 12:51 PM
Critical Survey: OncoGenex Pharmaceuticals (ACHV) & The CompetitionCritical Survey: OncoGenex Pharmaceuticals (ACHV) & The Competition
www.americanbankingnews.com - November 10 at 3:10 AM
Achieve Reports Financial Results for Third Quarter 2017Achieve Reports Financial Results for Third Quarter 2017
finance.yahoo.com - November 9 at 4:24 PM
Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017
finance.yahoo.com - November 8 at 5:23 PM
Achieve Announces Availability of Company Presentation from the Virtual Investor ConferenceAchieve Announces Availability of Company Presentation from the Virtual Investor Conference
finance.yahoo.com - November 6 at 4:09 PM
Financial Contrast: OncoGenex Pharmaceuticals (ACHV) and The CompetitionFinancial Contrast: OncoGenex Pharmaceuticals (ACHV) and The Competition
www.americanbankingnews.com - November 3 at 1:10 PM
Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017
finance.yahoo.com - October 30 at 3:29 PM
Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of CytisineAchieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine
finance.yahoo.com - October 26 at 11:35 AM
CASI Pharmaceuticals (CASI) and OncoGenex Pharmaceuticals (ACHV) Critical ReviewCASI Pharmaceuticals (CASI) and OncoGenex Pharmaceuticals (ACHV) Critical Review
www.americanbankingnews.com - October 26 at 1:16 AM
Head to Head Review: OncoGenex Pharmaceuticals (ACHV) & The CompetitionHead to Head Review: OncoGenex Pharmaceuticals (ACHV) & The Competition
www.americanbankingnews.com - October 24 at 12:30 PM
Achieve Announces Advancement of Cytisine Clinical Development ProgramAchieve Announces Advancement of Cytisine Clinical Development Program
finance.yahoo.com - October 4 at 8:09 AM
BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2017 AGM and Awards Gala - Business Wire (press release)BioAlberta Recognizes Alberta Innovators and Entrepreneurs at 2017 AGM and Awards Gala - Business Wire (press release)
www.businesswire.com - September 23 at 8:40 PM
Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLCAchieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC
finance.yahoo.com - September 14 at 8:24 PM
Achieve Announces Initiation of Cytisine Clinical Development ProgramAchieve Announces Initiation of Cytisine Clinical Development Program
finance.yahoo.com - August 16 at 3:24 PM
Albany Molecular Research (AMRI) & OncoGenex Pharmaceuticals (ACHV) Critical ComparisonAlbany Molecular Research (AMRI) & OncoGenex Pharmaceuticals (ACHV) Critical Comparison
www.americanbankingnews.com - August 15 at 6:08 PM
Achieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation TreatmentAchieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation Treatment
finance.yahoo.com - August 10 at 4:51 PM
Affirmative Action Battle Has a New Focus: Asian-Americans - The ... - New York TimesAffirmative Action Battle Has a New Focus: Asian-Americans - The ... - New York Times
www.nytimes.com - August 4 at 12:47 PM

SEC Filings

Achieve Life Sciences (NASDAQ:ACHV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Achieve Life Sciences (NASDAQ:ACHV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Achieve Life Sciences (NASDAQ ACHV) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.